Upgrade to SI Premium - Free Trial

Form SCHEDULE 13D/A Core Scientific, Inc./tx Filed by: Situational Awareness LP

August 4, 2026 5:37 PM





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
The information set forth on this cover page reflects information as of the close of business on August 4, 2026. As of July 15, 2026, the Reporting Person may have been deemed to beneficially own 25,608,473 shares of Common Stock, representing 8.1% of the shares of Common Stock outstanding as of such time.


SCHEDULE 13D




Comment for Type of Reporting Person:
The information set forth on this cover page reflects information as of the close of business on August 4, 2026. As of July 15, 2026, the Reporting Person may have been deemed to beneficially own 25,608,473 shares of Common Stock, representing 8.1% of the shares of Common Stock outstanding as of such time.


SCHEDULE 13D




Comment for Type of Reporting Person:
The information set forth on this cover page reflects information as of the close of business on August 4, 2026. As of July 15, 2026, the Reporting Person may have been deemed to beneficially own 25,608,473 shares of Common Stock, representing 8.1% of the shares of Common Stock outstanding as of such time.


SCHEDULE 13D




Comment for Type of Reporting Person:
The information set forth on this cover page reflects information as of the close of business on August 4, 2026. As of July 15, 2026, the Reporting Person may have been deemed to beneficially own 25,608,473 shares of Common Stock, representing 8.1% of the shares of Common Stock outstanding as of such time.


SCHEDULE 13D




Comment for Type of Reporting Person:
The information set forth on this cover page reflects information as of the close of business on August 4, 2026. As of July 15, 2026, the Reporting Person may have been deemed to beneficially own 25,608,473 shares of Common Stock, representing 8.1% of the shares of Common Stock outstanding as of such time.


SCHEDULE 13D




Comment for Type of Reporting Person:
The information set forth on this cover page reflects information as of the close of business on August 4, 2026. As of July 15, 2026, the Reporting Person may have been deemed to beneficially own 25,608,473 shares of Common Stock, representing 8.1% of the shares of Common Stock outstanding as of such time.


SCHEDULE 13D


Situational Awareness LP
Signature:/s/ Leopold Aschenbrenner
Name/Title:Leopold Aschenbrenner, Managing Partner
Date:08/04/2026
SAF AI GP LP
Signature:/s/ Leopold Aschenbrenner
Name/Title:Leopold Aschenbrenner, Managing Partner
Date:08/04/2026
Situational Awareness LLC
Signature:/s/ Leopold Aschenbrenner
Name/Title:Leopold Aschenbrenner, Manager
Date:08/04/2026
Situational Awareness Partners LP
Signature:/s/ Leopold Aschenbrenner
Name/Title:Leopold Aschenbrenner, Managing Partner of SAF AI GP LP, general partner of Situational Awareness Partners LP
Date:08/04/2026
Leopold Aschenbrenner
Signature:/s/ Leopold Aschenbrenner
Name/Title:Leopold Aschenbrenner, Individually
Date:08/04/2026
Carl Shulman
Signature:/s/ Carl Shulman
Name/Title:Carl Shulman, Individually
Date:08/04/2026

ATTACHMENTS / EXHIBITS

TRANSACTIONS IN THE PAST 60 DAYS

Categories

SEC Filings